You are here » Home » Companies » Company Overview » Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Ltd.

BSE: 532989 Sector: Health care
NSE: BAFNAPH ISIN Code: INE878I01022
BSE 00:00 | 09 Apr 2020 Bafna Pharmaceuticals Ltd is not traded on BSE in the last 30 days
NSE 05:30 | 01 Jan 1970 Bafna Pharmaceuticals Ltd is not traded on NSE in the last 30 days

Notice: Undefined property: stdClass::$market_capital_for_nse in /usr2/unibs/application/modules/live-market/views/scripts/company/bs-new-bse-nse-block.php on line 17
OPEN 9.76
PREVIOUS CLOSE 9.76
VOLUME 110
52-Week high 9.88
52-Week low 4.65
P/E
Mkt Cap.(Rs cr) 2
Buy Price 9.76
Buy Qty 9903.00
Sell Price 5.10
Sell Qty 2.00
OPEN 9.76
CLOSE 9.76
VOLUME 110
52-Week high 9.88
52-Week low 4.65
P/E
Mkt Cap.(Rs cr) 2
Buy Price 9.76
Buy Qty 9903.00
Sell Price 5.10
Sell Qty 2.00

About Bafna Pharmaceuticals Ltd.

Bafna Pharmaceuticals Ltd

Bafna was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products. The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p....> More

Bafna Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   2
EPS - TTM () [*S] -
P/E Ratio (X) [*S] -
Face Value ()   10
Latest Dividend (%)   6.00
Latest Dividend Date 19 Sep 2013
Dividend Yield (%) 0.00
Book Value / Share () [*S] -13.59
P/B Ratio () [*S] -0.72
[*C] Consolidated     [*S] Standalone    

Bafna Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Dec 2019 Dec 2018 % Chg
Net Sales 10.93 13.07 -16.37
Other Income 0.03 0.31 -90.32
Total Income 10.96 13.39 -18.15
Total Expenses 32.42 11.9 172.44
Operating Profit -21.46 1.48 -1550
Net Profit -22.33 0.06 -37316.67
Equity Capital 2.37 23.66 -
> More on Bafna Pharmaceuticals Ltd Financials Results

Bafna Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Sanjiv.Parant. 7.44 -1.46 4.39
Colinz Labs 8.47 4.96 3.87
Ishita Drugs 12.20 -3.48 3.65
Beryl Drugs 4.50 2.97 2.28
Bacil Pharma 1.80 4.65 1.06
Welcure Drugs 0.44 4.76 0.59
> More on Bafna Pharmaceuticals Ltd Peer Group

Bafna Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 26.36
Banks/FIs 0.00
FIIs 0.00
Insurance 0.00
Mutual Funds 0.00
Indian Public 62.35
Custodians 0.00
Other 11.29
> More on Bafna Pharmaceuticals Ltd Share Holding Pattern

Bafna Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week NA NA -0.83% -1.21%
1 Month NA 93.81% 17.44% 17.35%
3 Month NA NA -24.72% -25.26%
6 Month NA NA -19.72% -20.96%
1 Year NA 117.65% -19.79% -21.93%
3 Year -68.10% -33.93% 5.64% -0.69%

Bafna Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 9.76
9.76
Week Low/High 0.00
9.76
Month Low/High 9.30
10.00
YEAR Low/High 4.65
10.00
All TIME Low/High 4.65
60.00